Universal CAR-T Cells (REVO-UWD-00B)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Universal CAR-T Cells (REVO-UWD-00B), covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma [EARLY_Phase 1]